Safety - Determined by Major Adverse Cardiac and Cerebral Events (MACCE) Up to 36 months [clinicaltrials_resource:28cfa006bcab878423d4f77dfb10ae73]

Safety - Determined by Major Adverse Cardiac and Cerebral Events (MACCE) Up to 36 months [clinicaltrials_resource:28cfa006bcab878423d4f77dfb10ae73]

Dose escalation
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:28cfa006bcab878423d4f77dfb10ae73
A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium [clinicaltrials:NCT00426868]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Safety - Determined by Major Adverse Cardiac and Cerebral Events (MACCE) Up to 36 months [clinicaltrials_resource:28cfa006bcab878423d4f77dfb10ae73]

Dose escalation
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:28cfa006bcab878423d4f77dfb10ae73
Bio2RDF identifier
28cfa006bcab878423d4f77dfb10ae73
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:28cfa006bcab878423d4f77dfb10ae73
measure [clinicaltrials_vocabulary:measure]
Safety - Determined by Major Adverse Cardiac and Cerebral Events (MACCE)
time frame [clinicaltrials_vocabulary:time-frame]
description
identifier
clinicaltrials_resource:28cfa006bcab878423d4f77dfb10ae73
title
Safety - Determined by Major Adverse Cardiac and Cerebral Events (MACCE) Up to 36 months
@en
inDataset
type
label
Safety - Determined by Major A ...... fa006bcab878423d4f77dfb10ae73]
@en